TY  - JOUR

T1  - Sensitization of human cancer cells to gemcitabine by the Chk1 inhibitor MK-8776: cell cycle perturbation and impact of administration schedule in vitro and in vivo

JO  - BMC Cancer

UR  - http://dx.doi.org/10.1186/1471-2407-13-604

PY  - 2013/12/21

AU  - Montano R

AU  - Thompson R

AU  - Chung I

AU  - Hou H

AU  - Khan N

AU  - Eastman A

ED  - 

DO  - DOI: 10.1186/1471-2407-13-604

PB  - Springer Science and Business Media LLC

VL  - 13

IS  - 1

Y2  - 2024/09/19

ER  -